GlaxoSmithKline Seeks to Sell Flu Vaccine in U.S.
- Share via
GlaxoSmithKline is hoping to enter the U.S. flu-vaccine market, citing the nationwide shortage last year that led to lines for the vaccines.
The company applied to the Food and Drug Administration for permission to sell Fluarix, which is sold in more than 75 countries.
More From the Los Angeles Times
Podcasts
The latest effort is coming from the L.A. County Board of Supervisors. They just announced a $3 million program in conjunction with some nonprofits groups to test and clean the soil at homes still standing in the areas impacted by the Eaton Fire.
California once bet big on offshore wind to help power its clean-energy future, but the Trump administration is now paying developers billions to walk away from their projects. As California’s remaining offshore-wind leases hang in the balance, the state is fighting back in court.
The Hillside Strangler murders terrorized Los Angeles in the late 1970s. The killers were a pair of sadistic cousins. One confessed. The other was set to stand trial—until L.A. prosecutors flinched.
